...
首页> 外文期刊>Cell transplantation >Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.
【24h】

Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.

机译:自体骨髓细胞移植可增加由于周围动脉疾病而导致的严重危重肢体缺血患者的腿部灌注并减少截肢。

获取原文
获取原文并翻译 | 示例
           

摘要

Bone marrow cell transplantation has been shown to induce angiogenesis and thus improve ischemic artery disease. This study evaluates the effects of intramuscular bone marrow cell transplantation in patients with limb-threatening critical limb ischemia with a very high risk for major amputation. After failed or impossible operative and/or interventional revascularization and after unsuccessful maximum conservative therapy, 51 patients with impending major amputation due to severe critical limb ischemia had autologous bone marrow cells (BMC) transplanted into the ischemic leg. Patients 1-12 received Ficoll-isolated bone marrow mononuclear cells (total cell number 1.1 +/- 1.1 x 10(9)), patients 13-51 received point of care isolated bone marrow total nucleated cells (3.0 +/- 1.7 x 10(9)). Limb salvage was 59% at 6 months and 53% at last follow-up (mean 411 +/- 261 days, range 175-1186). Perfusion measured with ankle-brachial index (ABI) and transcutaneous oxygen tension (tcpO(2)) at baseline and after 6 months increased in patients with consecutive limb salvage (ABI 0.33 +/- 0.18 to 0.46 +/- 0.15, tcpO(2) 12 +/- 12 to 25 +/- 15 mmHg) and did not change in patients eventually undergoing major amputation. No difference in clinical outcome between the isolation methods were seen. Clinically most important, patients with limb salvage improved from a mean Rutherford category of 4.9 at baseline to 3.3 at 6 months (p = 0.0001). Analgesics consumption was reduced by 62%. Total walking distance improved in nonamputees from zero to 40 m. Three severe periprocedural adverse events resolved without sequelae, and no unexpected long-term adverse events occurred. In no-option patients with end-stage critical limb ischemia due to peripheral artery disease, bone marrow cell transplantation is a safe procedure that can improve leg perfusion sufficiently to reduce major amputations and permit durable limb salvage.
机译:骨髓细胞移植已显示可诱导血管生成,从而改善缺血性动脉疾病。这项研究评估了肌内骨髓细胞移植对严重肢体高度危险的威胁肢体的严重肢体缺血患者的疗效。在失败或无法进行的手术和/或介入性血运重建以及最大保守治疗失败之后,由于严重的严重肢体缺血而即将截肢的51例患者已将自体骨髓细胞(BMC)移植到了缺血小腿中。患者1-12接受Ficoll分离的骨髓单核细胞(总细胞数1.1 +/- 1.1 x 10(9)),患者13-51接受护理点分离的骨髓总有核细胞(3.0 +/- 1.7 x 10 (9))。肢体抢救在6个月时为59%,在最后一次随访时为53%(平均411 +/- 261天,范围175-1186)。在连续肢体抢救(ABI 0.33 +/- 0.18至0.46 +/- 0.15,tcpO(2)的患者中,基线和6个月后以踝肱指数(ABI)和经皮氧气张力(tcpO(2))测量的灌注增加)12 +/- 12至25 +/- 15 mmHg),并且在最终进行大面积截肢的患者中没有变化。分离方法之间的临床结果无差异。临床上最重要的是,肢体抢救患者的平均卢瑟福类别从基线的4.9提高到6个月的3.3(p = 0.0001)。镇痛药的消耗量减少了62%。非截肢者的总步行距离从零提高到40 m。三例严重的围手术期不良事件得以解决,没有后遗症,也未发生意外的长期不良事件。对于因外周动脉疾病而导致终末期严重肢体缺血的无选择患者,骨髓细胞移植是一种安全的方法,可以充分改善腿部灌注以减少大面积截肢并允许持久地挽救肢体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号